Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01277250 · ClinicalTrials.gov registry record · Phase 4
Web-based Smoking Cessation Intervention: Transition From Inpatient to Outpatient
A Phase 4 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,548
- Enrollment target
NCT01277250 is a Phase 4 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 1,548 participants.
The verdict
NCT01277250, a Phase 4 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,548 participants
- Enrollment target
Study Summary
This project, "Web-based Smoking Cessation Intervention: transition from inpatient to outpatient," addresses smoking among hospitalized patients, whose rates are higher than among the general population. Hospitalization offers a unique opportunity to intervene, as it requires temporary abstinence and patients are focused on health concerns. Hypotheses: A tailored web-based and e-message smoking cessation program for current smokers that, upon hospital discharge, transitions the patient to continue a quit attempt when home will be effective. Further, the investigators hypothesize that this approach will be cost-effective. Specific Aims: 1. To test the effectiveness of a web-based smoking cessation intervention. 2. To determine the cost-effectiveness of this approach. Research Design - Methods: A randomized two-arm follow-up design will be used to test the effectiveness of an evidence- and theoretically-based smoking cessation program designed for post-hospitalization. Patients randomized to this arm will be contacted by hospital staff, trained as 'transition coaches,' to engage in Decide2Quit, an interactive web-based program that offers personalized and tailored messages, e-group support, and text messages promoting tobacco abstinence. All hospitalized patients will receive standardized smoking cessation materials. As well, physicians can order nicotine replacement therapy via the hospital's electronic order system. The investigators primary outcome is biologically confirmed and self-reported tobacco abstinence at 6 months follow-up; the investigators will also assess self-reported quit rates at 3 and 12 months and variables hypothesized to predict quit success. We will measure health care utilization and quality of life to allow testing the cost-effectiveness of this program conducted from the perspective of a hospital, health care payers, patients and society. Significance of results: At study completion the investigators will know whether imbedding smoking cessat
Interventions
- BEHAVIORAL Web-based smoking cessation program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,548 participants |
| Start Date | 2011-07 |
| Est. Completion | 2014-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01277250
The ClinicalTrials.gov registry entry for NCT01277250 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,548 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Web-based smoking cessation program is the first listed.
NCT01277250 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01277250 about?
NCT01277250 is a clinical study titled "Web-based Smoking Cessation Intervention: Transition From Inpatient to Outpatient". This project, "Web-based Smoking Cessation Intervention: transition from inpatient to outpatient," addresses smoking among hospitalized patients, whose rates are higher than among the general population. Hospitalization offers a unique opportunity to intervene, as it requires temporary abstinence an...
What is the current status of trial NCT01277250?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,548 participants. The study started on 2011-07. Estimated completion is 2014-11.
What interventions are being tested in trial NCT01277250?
The interventions under investigation include: Web-based smoking cessation program (BEHAVIORAL).
Who is sponsoring clinical trial NCT01277250?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.